Archived Newsletters

  1. 07.18.25 -- Why CDMOs Are Leaving Small Molecules Behind 7/18/2025
    07/18/25 Outsourced Pharma Newsletter
  2. 07.17.25 -- Innovation driving access in advanced therapies 7/17/2025

    07/17/25 Outsourced Pharma Newsletter

  3. 07.17.25 -- Techniques To Streamline Development From Feasibility To Launch 7/17/2025

    07/17/25 Outsourced Pharma Newsletter

  4. 07.17.25 -- The FDA Was Darned Near Perfect, Right? 7/17/2025
    07/17/25 Outsourced Pharma Newsletter
  5. 07.16.25 -- Fix Your CGT Launch Plan: Speed Isn't the Problem. Strategy Is. 7/16/2025

    07/16/25 Outsourced Pharma Newsletter

  6. 07.16.25 -- Breaking Barriers: 3D Screen Printing Transforms Drug Formulation 7/16/2025

    07/16/25 Outsourced Pharma Newsletter

  7. 07.16.25 -- The FDA Was Darned Near Perfect, Right? 7/16/2025
    07/16/25 Outsourced Pharma Newsletter
  8. 07.15.25 -- Elevate Your Biologics: Cell Line, Tox Studies, & FIH Acceleration 7/15/2025

    07/15/25 Outsourced Pharma Newsletter

  9. 07.15.25 -- The FDA Was Darned Near Perfect, Right? 7/15/2025
    07/15/25 Outsourced Pharma Newsletter
  10. 07.14.25 -- STREAM Edition: Identify And Quantify AAV Fill States Using Analytical Ultracentrifugation 7/14/2025

    07/14/25 Outsourced Pharma Newsletter